Rethinking HIV pre-exposure prophylaxis prevention strategy

Jesne Kistan, David Serwadda

The prevalence of HIV in young South African women aged 20–24 years is three times higher than that in their male counterparts. Young South African women are a key population group that contributes to 30% of all new infections in the country, highlighting the need for effective HIV prevention strategies in this population. Although HIV oral pre-exposure prophylaxis (PrEP) has proven effective in several clinical trials, vaginal and oral PrEP have failed in studies involving women in South Africa. In particular, adherence to PrEP has been low in clinical trials. HIV prevention strategies applied in clinical trial settings of young South African women can lack the cultural, socioeconomic, and historical background knowledge and insight to cater for the specific needs of this population. A PrEP panacea might, therefore, not be an achievable goal.

April 18, 2016
Year of publication
Resource types
Journal and research articles
young women, South Africa, HIV prevention strategies, pre-exposure prophylaxis (PrEP), oral PrEP, PrEP, adherence, HIV prevention

Similar Resources

Gender-based power imbalances place women at significant risk for sexual violence, however, little research has examined this association among women living with HIV/AIDS.

A new study of the impact of cytotoxic T lymphocyte (CTL) escape mutations suggests that holes in the host immune repertoire contribute to poor disease outcomes, owing to a gradual deterioration of the host anti-HIV-1 immune response.

Multipurpose prevention technologies (MPTs) are preferably single dosage forms designed to simultaneously address multiple sexual and reproductive health needs, such as unintended pregnancy, HIV infection and other sexually transmitted infections (STIs).

Adolescent girls and young women (AGYW), ages 15–24 years, account for 75 percent of young people in sub-Saharan Africa who are living with HIV.  As many as 7,000 new infections a week are occurring among the most vulnerable AGYW in Eastern and Southern Africa; AIDS is the …

In sub-Saharan Africa, young women ages 15-24 have more than twice the risk of acquiring HIV as their male counterparts. A growing body of epidemiological evidence suggests that the practice of "transactional sex" may contribute to this disparity.

Engaging women in the dialogue on VMMC can have broad impacts on voluntary medical male circumcision (VMMC) programs, especially when women become aware that circumcision can reduce HIV risk.

Young women in their late teens and early twenties are especially susceptible to HIV infection in developing nations, as incidence of HIV is growing most rapidly among females aged 15–24 years.

Women globally need access to multipurpose prevention technologies (MPTs) that prevent human immunodeficiency virus (HIV), sexually transmitted infections that increase HIV acquisition/transmission risk, and unintended pregnancy.

Topical prevention of HIV and other STIs is a global health priority. To provide options for users, developers have worked to design safe, effective and acceptable vaginal dissolving film formulations.

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy.